Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1
Reverse Transcriptase Inhibitors
#MMPMID24970195
Schauer G
; Leuba S
; Sluis-Cremer N
Biomolecules
2013[Nov]; 3
(4
): 889-904
PMID24970195
show ga
HIV-1 reverse transcriptase (RT) plays a central role in HIV infection. Current
United States Federal Drug Administration (USFDA)-approved antiretroviral
therapies can include one of five approved non-nucleoside RT inhibitors (NNRTIs),
which are potent inhibitors of RT activity. Despite their crucial clinical role
in treating and preventing HIV-1 infection, their mechanism of action remains
elusive. In this review, we introduce RT and highlight major advances from
experimental and computational biophysical experiments toward an understanding of
RT function and the inhibitory mechanism(s) of NNRTIs.